Physiological and pharmacological properties of vanadium
- 3 October 1983
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 33 (14) , 1325-1340
- https://doi.org/10.1016/0024-3205(83)90816-0
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Vanadate increases oxygen affinity and affects enzyme activities and membrane properties of erythrocytesBiochemical and Biophysical Research Communications, 1981
- Effect of vanadate on phosphoryl transfer enzymes involved in glucose metabolismBiochemical and Biophysical Research Communications, 1981
- Reduction of Vanadate by Ascorbic Acid and Noradrenaline in SynaptosomesJournal of Neurochemistry, 1981
- Vanadate inhibits 2,3-bisphosphoglycerate dependent phosphoglycerate mutases but does not affect the 2,3-bisphosphoglycerate independent phosphoglycerate mutasesBiochemical and Biophysical Research Communications, 1980
- Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranesBasic Research in Cardiology, 1980
- Effect of vanadate on myocardial force of contractionBasic Research in Cardiology, 1980
- Cardiac effects of vanadateBasic Research in Cardiology, 1980
- Vanadate inhibition of sarcoplasmic reticulum Ca2+-ATPase and other ATPasesBiochemical and Biophysical Research Communications, 1979
- Effects of vanadate on cardiac contraction and adenylate cyclaseBiochemical and Biophysical Research Communications, 1979
- Deficiency of erythrocyte sodium pump activity in bipolar manic-depressive psychosisLife Sciences, 1974